Literature DB >> 21173051

Republished: Which antibody and which cancer in which paraneoplastic syndromes?

Paul Gozzard1, Paul Maddison.   

Abstract

Paraneoplastic neurological syndromes can be associated with the presence of onconeural antibodies. These antibodies are the result of an immune response against a tumour that is ectopically expressing a neuronal antigen. The 'classical' onconeural antibodies (anti-Hu, Yo, Ma2, CRMP-5, amphiphysin and Ri) are directed against intracellular antigens and are strongly associated with underlying malignancy. By contrast, onconeural antibodies directed against cell surface antigens (eg, anti-NMDA, VGKC, AChR) have a weaker tumour association. This article gives a practical overview of the tumour associations, and the neurological associations, of the onconeural antibodies. There is also guidance on how to investigate occult malignancy in antibody positive cases.

Entities:  

Year:  2011        PMID: 21173051     DOI: 10.1136/jnnp.2010.224105rep

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Multi-domain cognitive impairment disclosed before the diagnosis of chronic lymphocytic leukaemia: an autoimmune/paraneoplastic disorder?

Authors:  Silvia Bernardi; Lorenzo De Nardis; Enrica Macci; Marco Fiorelli; Ada Francia
Journal:  Neurol Sci       Date:  2012-06-27       Impact factor: 3.307

2.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

3.  Paraneoplastic neurologic syndrome: A practical approach.

Authors:  Sudheeran Kannoth
Journal:  Ann Indian Acad Neurol       Date:  2012-01       Impact factor: 1.383

4.  Clinical Spectrum, Therapeutic Outcomes and Prognostic predictors in Paraneoplastic Neurological Syndromes - Experiences from a Tertiary Care Center in India.

Authors:  Asish Vijayaraghavan; Pullumpallil Thomas Alexander; Aditya Vijayakrishnan Nair; Ajith Sivadasan; Arun Mathai Mani; Donna Mathew; Atif Shaikh; Rohit Ninan Benjamin; A T Prabhakar; John Jude; Sunithi Mani; Sanjith Aaron; Vivek Mathew; Mathew Alexander
Journal:  Ann Indian Acad Neurol       Date:  2021-02-09       Impact factor: 1.383

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.